Astrazeneca (AZN)

 

AZN Share PerformanceMore

52 week high5,520 22/06/17
52 week low4,260 27/07/17
52 week change 269 (5.16%)
4 week volume52,399,740 29/04/18
price5,478
price date1527270316
close5,428

Latest NewsMore

FTSE closes up after seesaw afternoon

Sterling weakness helped the FTSE 100 to close higher ahead of the Bank Holiday weekend. By the end of trading on Friday...

FTSE stalls as UK growth fears confirmed

After a boost this morning from North Korea's concillatory tone on a cancelled US summit the FTSE 100 was losing some ...

Broker Forecast - Shore Capital issues a broker note on AstraZeneca PLC

Shore Capital today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and set its price target at 5428p. ...

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and set its price target at 500...

UK stocks open stronger as North Korea tensions cool

UK stocks opened higher on Friday as North Korea struck a more conciliatory tone with the US following yesterday's dete...

AstraZeneca lung cancer treatment shows positive results in clinical trial

AstraZeneca said Friday the phase III Pacific trial of its lung cancer treatment showed positive overall survival results in lu...

AZ's Imfinzi: significant OS in Stage III nsclc

RNS Number: 2684P AstraZeneca PLC 25 May 2018 This announcement contains inside information 25 May 2018 07:00 BST Imfinzi significantly improves overall survival in the Phase III PACIFIC trial for unresectable Stage III non-small cell lung cancer Imfinzi met the second primary endpoint of overall survival which was both statistically-significant and clinical...

Strong US open boosts FTSE

The FTSE 100 remained in positive territory on a strong performance on Wall Street as investors were relieved a potential t...

Latest discussion posts More

  • AstraZeneca successful in late-state lung cancer study

    A Phase 3 clinical trial, PACIFIC, assessing AstraZeneca's (NYSE:AZN) Imfinzi (durvalumab) in patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose ...
    25-May-2018
    Proverbs 26 vs 5
  • Re: Selling signal?

    " I've been holding for 4 years from around the time of the Pfizer bid. " Blimey, have four years really passed since the Pfizer bid? It seems like yesterday.
    24-May-2018
    FRTEB
  • Re: Selling signal?

    I wouldn't call a top on this one, sales and profits have been falling for the past few years and the share price keeps going up. I've been in this one since the Astra days, ...
    23-May-2018
    maaark1

Users' HoldingsMore

Users who hold Astrazeneca also hold..
HSBC HLDGS.UK100%
IGAS ENERGY66%
MAN GROUP66%
TESCO66%
ISH COREFTSE10066%

Codes & Symbols

ISINGB0009895292
SymbolsAZN, LSE:AZN, AZN.L, AZN:LN, LON:AZN, XLON:AZN